Petros Pharmaceuticals Inc
Save
4.74M
Market cap
Current P/E
Forward P/E

About

Health care
Sector
Drug Manufacturers - Specialty & Generic
Industry

Petros Pharmaceuticals, Inc., a pharmaceutical company, focuses on men's health therapeutics. The company engages in the commercialization and development of Stendra, an PDE-5 inhibitor prescription medication for the treatment of erectile dysfunction (ED). It also develops and commercializes H100, a patented topical formulation candidate for the treatment of acute Peyronie's disease.

Similar securities

Based on sector and market capitalization

Report issue